These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 31810919)

  • 21. c-Met-mediated reactivation of PI3K/AKT signaling contributes to insensitivity of BRAF(V600E) mutant thyroid cancer to BRAF inhibition.
    Byeon HK; Na HJ; Yang YJ; Kwon HJ; Chang JW; Ban MJ; Kim WS; Shin DY; Lee EJ; Koh YW; Yoon JH; Choi EC
    Mol Carcinog; 2016 Nov; 55(11):1678-1687. PubMed ID: 26456083
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Juglone potentiates BRAF inhibitor‑induced apoptosis in melanoma through reactive oxygen species and the p38‑p53 pathway.
    Li Z; Liu X; Li M; Chai J; He S; Wu J; Xu J
    Mol Med Rep; 2020 Jul; 22(1):566-574. PubMed ID: 32377702
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Involvement of superoxide and nitric oxide in BRAF(V600E) inhibitor PLX4032-induced growth inhibition of melanoma cells.
    Yu L; Gao LX; Ma XQ; Hu FX; Li CM; Lu Z
    Integr Biol (Camb); 2014 Dec; 6(12):1211-7. PubMed ID: 25363644
    [TBL] [Abstract][Full Text] [Related]  

  • 24. IL6/STAT3 axis mediates resistance to BRAF inhibitors in thyroid carcinoma cells.
    Notarangelo T; Sisinni L; Trino S; Calice G; Simeon V; Landriscina M
    Cancer Lett; 2018 Oct; 433():147-155. PubMed ID: 29969659
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pin1 inhibition potently suppresses gastric cancer growth and blocks PI3K/AKT and Wnt/β-catenin oncogenic pathways.
    Zhang Z; Yu W; Zheng M; Liao X; Wang J; Yang D; Lu W; Wang L; Zhang S; Liu H; Zhou XZ; Lu KP
    Mol Carcinog; 2019 Aug; 58(8):1450-1464. PubMed ID: 31026381
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential expression of ABCB5 in BRAF inhibitor-resistant melanoma cell lines.
    Xiao J; Egger ME; McMasters KM; Hao H
    BMC Cancer; 2018 Jun; 18(1):675. PubMed ID: 29929490
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PIN1 facilitates ubiquitin-mediated degradation of serine/threonine kinase 3 and promotes melanoma development via TAZ activation.
    Kim G; Bhattarai PY; Lim SC; Kim JY; Choi HS
    Cancer Lett; 2021 Feb; 499():164-174. PubMed ID: 33253791
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A chondroitin sulfate proteoglycan 4‑specific monoclonal antibody inhibits melanoma cell invasion in a spheroid model.
    Uranowska K; Samadaei M; Kalic T; Pinter M; Breiteneder H; Hafner C
    Int J Oncol; 2021 Sep; 59(3):. PubMed ID: 34318902
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pin1 Downregulation Is Involved in Excess Retinoic Acid-Induced Failure of Neural Tube Closure.
    Chen Y; Pang J; Ye L; Zhang Z; Kang J; Qiu Z; Lin N; Liu H
    Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38891776
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pin1 modulates chemo-resistance by up-regulating FoxM1 and the involvements of Wnt/β-catenin signaling pathway in cervical cancer.
    Wang T; Liu Z; Shi F; Wang J
    Mol Cell Biochem; 2016 Feb; 413(1-2):179-87. PubMed ID: 26820938
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Arsenic targets Pin1 and cooperates with retinoic acid to inhibit cancer-driving pathways and tumor-initiating cells.
    Kozono S; Lin YM; Seo HS; Pinch B; Lian X; Qiu C; Herbert MK; Chen CH; Tan L; Gao ZJ; Massefski W; Doctor ZM; Jackson BP; Chen Y; Dhe-Paganon S; Lu KP; Zhou XZ
    Nat Commun; 2018 Aug; 9(1):3069. PubMed ID: 30093655
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Berberine Inhibits Human Melanoma A375.S2 Cell Migration and Invasion via Affecting the FAK, uPA, and NF-κB Signaling Pathways and Inhibits PLX4032 Resistant A375.S2 Cell Migration In Vitro.
    Liu JF; Lai KC; Peng SF; Maraming P; Huang YP; Huang AC; Chueh FS; Huang WW; Chung JG
    Molecules; 2018 Aug; 23(8):. PubMed ID: 30104528
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Retinoic acid and the histone deacetylase inhibitor trichostatin a inhibit the proliferation of human renal cell carcinoma in a xenograft tumor model.
    Touma SE; Goldberg JS; Moench P; Guo X; Tickoo SK; Gudas LJ; Nanus DM
    Clin Cancer Res; 2005 May; 11(9):3558-66. PubMed ID: 15867260
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The MEK1/2 inhibitor AS703026 circumvents resistance to the BRAF inhibitor PLX4032 in human malignant melanoma cells.
    Park SJ; Hong SW; Moon JH; Jin DH; Kim JS; Lee CK; Kim KP; Hong YS; Choi EK; Lee JS; Lee JL; Kim TW
    Am J Med Sci; 2013 Dec; 346(6):494-8. PubMed ID: 24051957
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Resistance to selective BRAF inhibition can be mediated by modest upstream pathway activation.
    Su F; Bradley WD; Wang Q; Yang H; Xu L; Higgins B; Kolinsky K; Packman K; Kim MJ; Trunzer K; Lee RJ; Schostack K; Carter J; Albert T; Germer S; Rosinski J; Martin M; Simcox ME; Lestini B; Heimbrook D; Bollag G
    Cancer Res; 2012 Feb; 72(4):969-78. PubMed ID: 22205714
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The positive correlation between drug addiction and drug dosage in vemurafenib-resistant melanoma cells is underpinned by activation of ERK1/2-FRA-1 pathway.
    Rao M; Shi B; Yuan Y; Wang Y; Chen Y; Liu X; Li X; Zhang M; Liu X; Sun X
    Anticancer Drugs; 2020 Nov; 31(10):1026-1037. PubMed ID: 32868647
    [TBL] [Abstract][Full Text] [Related]  

  • 37. RNA-interference-mediated downregulation of Pin1 suppresses tumorigenicity of malignant melanoma A375 cells.
    Jin J; Zhang Y; Li Y; Zhang H; Li H; Yuan X; Li X; Zhou W; Xu B; Zhang C; Zhang Z; Zhu L; Chen X
    Neoplasma; 2013; 60(1):92-100. PubMed ID: 23067222
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SUV39H1/DNMT3A-dependent methylation of the RB1 promoter stimulates PIN1 expression and melanoma development.
    Kim G; Kim JY; Lim SC; Lee KY; Kim O; Choi HS
    FASEB J; 2018 Oct; 32(10):5647-5660. PubMed ID: 29750576
    [TBL] [Abstract][Full Text] [Related]  

  • 39. miR-204-5p and miR-211-5p Contribute to BRAF Inhibitor Resistance in Melanoma.
    Díaz-Martínez M; Benito-Jardón L; Alonso L; Koetz-Ploch L; Hernando E; Teixidó J
    Cancer Res; 2018 Feb; 78(4):1017-1030. PubMed ID: 29229605
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In Vitro Anticancer Effects of All-trans Retinoic Acid in Combination with Dacarbazine against CD117+ Melanoma Cells.
    Jobani BM; Mohebi E; Najafzadeh N
    Drug Res (Stuttg); 2020 Dec; 70(12):563-569. PubMed ID: 33022719
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.